This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.
For most consumers, product packaging represents their first impression of a brand and its sustainability credentials. But how is this push shaping the pharma packaging market and what are the key changes we can expect to see? For many, aesthetic appeal and user experience top the list of priorities when it comes to packaging design.
While much of the focus has been on how these cuts may impact application review timelines and industry engagement, see earlier post about the effect on generic drugs, another quieter consequence is emerging a significant slowdown in the availability of information that FDA is required to produce under the Freedom of Information Act (FOIA).
The decision was communicated through a Department of Health and Human Services (HHS) press release. It provides evidence-based recommendations on the use of vaccines for children and adults, informs decisions about insurance coverage, and helps determine eligibility for publicly funded programs such as Vaccines for Children (VFC).
Medical device packaging plays a key role in ensuring the safety, efficacy, and integrity of medical devices from the point of manufacture to the end-user. At Tjoapack, we are a premier provider of top-tier medical device packaging services. The packaging must adhere to guidelines set by authorities such as the FDA and EU GMP.
By providing clear information about our bioactives, we aim to boost consumer confidence, ultimately driving sales and improving profitability. At OmniActive, the emphasis is given to quality and efficacy through scientific validation, transparent communication, and credible endorsements.
As healthcare professionals, it’s our responsibility to educate patients about generic drugs and empower them to make informed decisions about their treatment options. Mobile Apps Develop or recommend mobile apps that provide information about generic drugs, compare prices, and offer medication reminders.
Table of Contents Why Pharma Podcasts Are Gaining Momentum The Best Pharma Marketing Podcasts in 2025 Top Drug Development and Biotech Podcasts Emerging Voices and Niche Pharma Shows Conclusion and FAQs Why Pharma Podcasts Are Gaining Momentum In today’s information-saturated world, audio content has carved out a unique advantage.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Present complex information in lists rather than paragraphs when possible. Use numbers rather words to convey numeric information, for example 'take 2 tablets.' capitals, bolding and highlighting) to communicate important information. Complete the course" for antibiotics, "May cause drowsiness" for sedating drugs, etc.)
Packaging plays a critical part in the pharmaceuticals and medical devices industries and is developed with its own set of security standards for the safety of consumers. The role of primary packaging has extended beyond the primary objectives of sterility, physical and chemical protection, and security.
In an article published here ten days back, I provided a detailed account of a most worrying case where counterfeiters succeeded in acquiring batch-specific serial numbers of Sun Pharmas anti-epileptic drug Levipil 500, which were then embedded into QR codes on fake packages. This is actually a positive feature [3].
Companies are investing heavily in digital tools to streamline communication and build stronger connections. Strategies like storytelling, personalized educational content, and two-way communication channels create trust and build loyalty. Patient-Centric Marketing Patients want to feel heard.
The session shed light on how disparities in manufacturing practices and varying quality standards, coupled with ineffective documentation and lack of transparency in communication, were hindering the industry’s growth. Embracing innovation in pharma packaging is vital become future Shivaji Chakraborty, Asst.
We may still continue to send you service-related and other non-promotional communications. For more information relating to our privacy practices, we invite you to review our privacy policy. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. Sign up for our daily news round-up!
Datwyler is a leading provider of parenteral packaging components and is helping the industry put quality first through the invention of the FirstLine® manufacturing standard. It also explores the causes of contamination and how parenteral packaging – one potential source – can be adapted to minimise the risk.
The communications vehicle in question was a social media sponsored posting. OPDP took issue with three specific aspects of the promotional communication. First, while presenting the indication in the posting, there was no risk information included in the communication. Pharma communicators take note.
Through EMA’s engagement with its stakeholders, the Medicines Shortages Steering Group has received up-to-date information from community pharmacists on the situation in pharmacies across the EU. Based on current information from companies and stakeholders, it is expected that the situation will improve in the coming months.
Assessing drug manufacturing facilities using alternative tools The FDA stated in the guidance that all manufacturing, packaging, and control sites for drug substance and drug product facilities are expected to be ready for inspection at the time of application submission.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Communication between the manufacturing plant and retail stores. The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. The facility expands on BASF’s existing network of GMP sites. BASF Pharma Solutions is a manufacturer of excipients and APIs.
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
By GlobalData Learn more about Strategic Intelligence Spire Healthcare CEO Justin Ash said: “This future partnership, and the innovative diagnostic technology developed by Genomics, will enable Spire to help people make informed choices about their health and lifestyle. Give your business an edge with our leading industry insights.
Take the time to clearly define your technical needs, from drug substance manufacturing to packaging requirements. Industry directories, conferences, and networking can all be valuable sources of information. Clear Communication is Key Establish clear channels of communication from the outset.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drug development. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Best resources for OTC drug information When it comes to over-the-counter (OTC) drugs, it’s important to have access to reliable and trustworthy information to ensure safe and effective use. Here are some resources that can provide you with the best information on OTC drugs.
One requirement that is included in Title II of the Act calls for product tracing at the package level, which had not been explored widely by the industry until recently. As we finalize this communication system and assist the boards of pharmacy , you might wonder what your pharmacy can do to prepare. Plenty, as you can see below!
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Under the research partnership and licensing agreement, Orion will obtain access to Glykos’ ADC technologies for probable expansion into three new programmes beyond those specified in the original agreement.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
By GlobalData Learn more about Strategic Intelligence Novo Nordisk is hoping to partner with a company which uses artificial intelligence (AI) to scan a person’s plate of food and provide them with information as to whether it is providing the necessary nutrition, notably protein, due to GLP-1RAs’ association with loss of muscle mass.
The recipient of the letter was Bausch Health Companies and it was in regard to two different communications vehicles – one a “DTC video” that appeared on Lifetime TV’s The Balancing Act – and the other the efficacy webpage of the healthcare professional website. The Context. There are a couple of things of note.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. Stay Informed and Updated Regulations in the pharmaceutical industry are constantly evolving. Keep thorough records of approvals for future reference.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. These standardised documents provide meticulously curated and scientifically approved information. Exploring the benefits of ePI ePI offers advantages, notably swift access to updated medication information.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content